We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

41 hedge funds and large institutions have $64.1M invested in Kindred Biosciences, Inc. in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more capital invested

Capital invested by funds: $45.3M → $64.1M (+$18.7M)

7% less funds holding

Funds holding: 44 → 41 (-3)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
41
Holders Change
-3
Holders Change %
-6.82%
% of All Funds
1.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
12
Reduced
15
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$873K
2
AI
Ariel Investments
Illinois
+$590K
3
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$137K
4
Renaissance Technologies
Renaissance Technologies
New York
+$122K
5
Prudential Financial
Prudential Financial
New Jersey
+$16.9K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$833K
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$480K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$33.8K
4
Goldman Sachs
Goldman Sachs
New York
-$19.9K
5
Morgan Stanley
Morgan Stanley
New York
-$15.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
Ariel Investments
Illinois
$19.1M +$590K +139,587 +4%
BG
2
Baupost Group
Massachusetts
$15M -$9.57K -2,264 -0.1%
PWAM
3
Park West Asset Management
California
$9.73M +$3.33K +789 +0%
EC
4
EcoR1 Capital
California
$7.15M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.16M +$5.92K +1,400 +0.3%
Renaissance Technologies
6
Renaissance Technologies
New York
$1.66M +$122K +28,900 +10%
New York State Common Retirement Fund
7
New York State Common Retirement Fund
New York
$1.59M – – –
Wells Fargo
8
Wells Fargo
California
$1.05M +$873K +206,638 +6,913%
RA
9
Royce & Associates
New York
$736K – – –
Fidelity Investments
10
Fidelity Investments
Massachusetts
$529K -$480K -113,492 -52%
Bank of America
11
Bank of America
North Carolina
$515K -$2.91K -688 -0.7%
SKK
12
Shepherd Kaplan Krochuk
Massachusetts
$473K +$137K +32,500 +52%
BCM
13
Bridgeway Capital Management
Texas
$399K – – –
JPC
14
Jackson Park Capital
Utah
$383K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$321K +$317 +75 +0.1%
Connor, Clark & Lunn Investment Management (CC&L)
16
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$316K +$3.38K +800 +1%
OWD
17
Osborn Williams & Donohoe
Ohio
$313K – – –
Prudential Financial
18
Prudential Financial
New Jersey
$297K +$16.9K +4,000 +7%
BIT
19
BlackRock Institutional Trust
California
$294K -$14K -3,316 -5%
OWIM
20
Old West Investment Management
California
$227K -$3.15K -746 -2%
BFA
21
BlackRock Fund Advisors
California
$214K -$249 -59 -0.1%
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$213K -$33.8K -8,000 -16%
Deutsche Bank
23
Deutsche Bank
Germany
$181K -$1.49K -353 -1%
UBS Group
24
UBS Group
Switzerland
$152K +$9.31K +2,203 +8%
Northern Trust
25
Northern Trust
Illinois
$127K -$296 -70 -0.3%
1
2

KIN Hedge Fund Activity: Q3 2016 in Review

41 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q3 2016, worth a combined $64.1M — up 41% from $45.3M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of KIN and 0 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 12 added.

The largest buyer was Wells Fargo, adding an estimated $873K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $833K sold.

  • 41 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q3 2016, down from 44 in Q2 2016.
  • Funds reported $64.1M of Kindred Biosciences, Inc. stock for Q3 2016, up 41% quarter-over-quarter.
  • 0 funds opened new Kindred Biosciences, Inc. positions in Q3 2016 and 3 closed out, a net change of -3 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q3 2016 was Wells Fargo, an estimated $873K added.
  • The largest Kindred Biosciences, Inc. seller in Q3 2016 was JP Morgan Chase, an estimated $833K sold.

Based on aggregated 13F filings for Q3 2016.